Home > Insider Trading > Filing (0000950142-16-004060)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1556263	Syros Pharmaceuticals Inc.	SYRS	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1172252	N Andrew Schiff	C/O Aisling Capital Llc 888 Seventh Ave., 12Th Floor New York NY 10106	No	No	Yes	No
1250195	Steve Elms	C/O Aisling Capital Llc 888 Seventh Ave., 12Th Floor New York NY 10106	No	No	Yes	No
1297291	J Dennis Purcell	C/O Aisling Capital Llc 888 Seventh Ave., 12Th Floor New York NY 10106	No	No	Yes	No
1444717	Aisling Capital Iii Lp	888 Seventh Ave., 12Th Floor New York NY 10106	No	No	Yes	No
1532634	Aisling Capital Partners Iii Lp	888 Seventh Ave., 12Th Floor New York NY 10106	No	No	Yes	No
1532635	Aisling Capital Partners Iii Llc	888 Seventh Ave., 12Th Floor New York NY 10106	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-07-06	508,565	$0.00	508,565	No	4	C	Direct
Common Stock	Acquisiton	2016-07-06	400,000	$12.50	908,565	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2016-07-06	1,907,122	$0.00	508,565	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

The Series B Preferred Stock converted into Common Stock on a 3.75-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
The securities are directly held by Aisling Capital III, LP ("Aisling"), and indirectly held by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members and partners (collectively, the "Managers") of Aisling GP and Aisling Partners. The Managers of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms.